Vaniam Group Bolsters Patient Engagement Strategy With Alexandra Dubois as Senior Vice President

CHICAGO, Sept. 23, 2025 /PRNewswire/ -- Vaniam Group is strengthening its focus on patient engagement with the appointment of Alexandra Dubois as Senior Vice President of Patient Engagement, a move that underscores the organization's ongoing commitment to placing authentic patient voices at the center of its work.

Dubois will work alongside Vaniam Group's scientific and strategic leaders to expand patient engagement capabilities and ensure that patient insights inform decision-making at every level. Her appointment is the next step in the company's commitment to elevating patient engagement, with further growth and expansion planned in the coming months.

"Our ability to bridge the gap between the biopharma community and patients relies on deeply understanding what matters most to those we serve," said Deanna B. van Gestel, Founder and CEO of Vaniam Group. "Alex's expertise and proven leadership will strengthen our ability to elevate patient voices and integrate their insights into actionable strategies that create lasting impact."

Dubois has 25 years of experience spanning both business-to-consumer and business-to-business sectors. She has spent more than a decade dedicated to patient engagement and is known for launching and leading The Px Group—a division of The CM Group—focused on patient-centered strategy, which continued to grow following its acquisition by OPEN Health.

At Vaniam Group, Dubois will play a leading role in expanding solutions that integrate the lived experiences of patients with cutting-edge scientific expertise, helping clients uncover unmet needs, enhance strategy, and inspire innovation.

"Vaniam Group has built a reputation for transforming complex science into human connections," Dubois said. "I'm thrilled to contribute to advancing an approach to patient engagement that not only amplifies their voices but ensures their experiences resonate throughout oncology and rare disease innovation."

Through its forward-thinking approach, Vaniam Group ensures the patient perspective is not just considered, but that it is prioritized. By translating patient voices into insights, the company helps biopharma innovators design strategies that drive meaningful connections and measurable outcomes across the healthcare landscape.

About Vaniam Group

Vaniam Group is the leading medical communications partner for biopharma innovators who seek to connect high science with human impact. By combining deep scientific expertise, actionable insights, and innovative technology, the company bridges the gap between the medical community and the patients they serve. With dedicated expertise in oncology, hematology, rare disease, and immunology, Vaniam Group drives meaningful dialogue, collaboration, and breakthroughs in care.

To learn more about how Vaniam Group is shaping the future of healthcare, visit vaniamgroup.com.

Media Contact:
Chay Hughes
Corporate Communications
[email protected]

SOURCE Vaniam Group LLC